Jim Simons Renaissance Technologies
AUM
$75.2B
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+16.98%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$75.2B
AUM Growth
+$75.2B
(+14%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
2.56%
Top 10 Holdings %
Top 10 Hldgs %
12.06%
Holding
4,018
New
612
Increased
1,568
Reduced
1,323
Closed
496
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Palantir
PLTR
$372B
| $1.84B | 2.45% | 13,502,046 -2,787,827 | -17% | -$380M |
|
|
2
NVIDIA
NVDA
$4.25T
| $1.17B | 1.56% | 7,422,744 +6,337,784 | +584% | +$1B |
|
|
3
Robinhood
HOOD
$91.8B
| $1.08B | 1.43% | 11,515,634 -5,140,782 | -31% | -$481M |
|
4
VeriSign
VRSN
$25.4B
| $944M | 1.26% | 3,267,369 +253,398 | +8% | +$73.2M |
|
|
5
Netflix
NFLX
$516B
| $721M | 0.96% | 538,528 +538,120 | +131,892% | +$721M |
|
6
Exelixis
EXEL
$10.2B
| $697M | 0.93% | 15,819,765 +995,500 | +7% | +$43.9M |
|
7
Spotify
SPOT
$139B
| $677M | 0.9% | 881,925 +61,732 | +8% | +$47.4M |
|
8
Sprouts Farmers Market
SFM
$13.7B
| $664M | 0.88% | 4,031,844 -231,900 | -5% | -$38.2M |
|
9
Roblox
RBLX
$86B
| $642M | 0.85% | 6,101,659 +10,200 | +0.2% | +$1.07M |
|
10
Gilead Sciences
GILD
$140B
| $628M | 0.84% | 5,666,392 +215,249 | +4% | +$23.9M |
|
|
11
GE Vernova
GEV
$169B
| $622M | 0.83% | 1,176,402 +710,600 | +153% | +$376M |
|
12
United Therapeutics
UTHR
$13.9B
| $609M | 0.81% | 2,119,092 +12,100 | +0.6% | +$3.48M |
|
13
DoorDash
DASH
$104B
| $607M | 0.81% | 2,464,188 +485,500 | +25% | +$120M |
|
14
Franco-Nevada
FNV
$35.5B
| $534M | 0.71% | 3,257,949 +227,400 | +8% | +$37.3M |
|
15
Kinross Gold
KGC
$24.9B
| $523M | 0.7% | 33,475,430 +1,023,636 | +3% | +$16M |
|
16
Applovin
APP
$162B
| $483M | 0.64% | 1,380,832 +501,632 | +57% | +$176M |
|
17
Ford
F
$46.9B
| $472M | 0.63% | 43,483,251 +24,143,142 | +125% | +$262M |
|
|
18
Apple
AAPL
$3.45T
| $469M | 0.62% | 2,286,262 +2,281,886 | +52,145% | +$468M |
|
19
Corcept Therapeutics
CORT
$7.3B
| $460M | 0.61% | 6,266,402 +123,371 | +2% | +$9.06M |
|
20
Vertex Pharmaceuticals
VRTX
$101B
| $447M | 0.6% | 1,004,888 -166,683 | -14% | -$74.2M |
|
|
21
UnitedHealth
UNH
$276B
| $422M | 0.56% | +1,352,129 | New | +$422M |
|
22
Nutanix
NTNX
$17.8B
| $389M | 0.52% | 5,094,400 +480,600 | +10% | +$36.7M |
|
23
Cboe Global Markets
CBOE
$24.8B
| $387M | 0.51% | 1,658,824 -59,400 | -3% | -$13.9M |
|
24
Etsy
ETSY
$5.33B
| $384M | 0.51% | 7,647,241 +2,353,000 | +44% | +$118M |
|
25
AbbVie
ABBV
$369B
| $364M | 0.48% | 1,961,998 +739,900 | +61% | +$137M |
|